For research use only. Not for therapeutic Use.
Vonlerolizumab (MOXR 0916) is a humanized IgG agonistic monoclonal OX40-specific antibody. Vonlerolizumab can be used for the research of cancer[1].
| Catalog Number | I043160 |
| CAS Number | 1638935-72-4 |
| Purity | ≥95% |
| Reference | [1]. Marin-Acevedo JA, et al. Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018 Mar 15;11(1):39. |
